RA Capital Reports New 5.8% Position In Recently Public Versartis Inc (VSAR)

Peter Kolchinsky’s RA Capital Management has initiated a new position in Versartis Inc (NASDAQ:VSAR). RA Capital owns 1.40 million shares of the company, a new filing with the Securities and Exchange Commission showed. The position is equates to 5.8% of common stock and is passive by nature.

Peter Kolchinsky

Recently, the company completed its initial public offering of 6.90 million common stock shares at a public offering price of $21 per share, which included 900,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares.  The company has a market cap of $676.1 million.

Versartis Inc (NASDAQ:VSAR) is an endocrine-focused biopharmaceutical company initially developing VRS-317, a novel, long-acting form of recombinant human growth hormone, for the treatment of growth hormone deficiency (GHD). VRS-317 is intended to reduce the burden of daily treatment by requiring significantly fewer injections, potentially improving compliance and, therefore, treatment outcomes. The company’s first targeted indication for VRS-317 is pediatric GHD, which represents an about $1.5 billion existing market opportunity.

Currently, the company is conducting the Phase 2a stage of its pediatric GHD clinical trial in which it is evaluating the dosing regimens of the drug. The company has global rights to VRS-317 and,  if it is approved, it intends to sell it via its own specialty sales force in the United States and Canada, as well as other regions.

Versartis Inc (NASDAQ:VSAR) is led by co-founder and chief executive officer Jeffrey L. Cleland. Aisling Capital, managed by Dennis Purcell, held a major stake in Versartis Inc (NASDAQ:VSAR) before the IPO, according to another filing.

Boston-based RA Capital invests in companies with promising drugs and technologies. In the beginning of this month, Ra Capital disclosed a new passive stake in Enanta Pharmaceuticals Inc (NASDAQ:ENTA), owning 1.54 million shares. Last month, RA Capital revealed initiating a new position in SANUWAVE Health Inc. (OTCBB:SNWV) and raising its stake in pSivida Corp. (NASDAQ:PSDV). In the first company, the fund has reported a 9.9% passive stake, which contains around 4.67 million shares. Also, the fund disclosed a new stake in Repros Therapeutics Inc (NASDAQ:RPRX), holding 1.44 million shares.

Disclosure: none

Recommended Reading:

Anchorage Advisors Sells Over 1 Million Shares In Central Pacific Financial Corp. (CPF)

Jeffrey Smith, Starboard Value are Bullish on Unwired Planet Inc (UPIP)

New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!